tsai chung-yi
Known title: CEO, PRESIDENT, CHAIRMANCIK: 0001859352
Associated companies
Transaction History
| AIMD | ▲ Buy | Grant | 50,000 | $105K | 11/25/2025 | View on chart |
| AIMD | ▲ Buy | Grant | 150,000 | $69K | 3/10/2025 | View on chart |
| AIMD | ▲ Buy | Grant | 1,468 | $998 | 1/31/2025 | View on chart |
| AIMD | ▲ Buy | Grant | 1,466 | $1K | 1/31/2024 | View on chart |
| AIMD | ▲ Buy | Grant | 250,000 | $150K | 11/24/2023 | View on chart |
| AIMD | ▲ Buy | Grant | 7,333 | $7K | 4/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Ainos Completes VELDONA Transfer and ASE Delivery
Ainos Inc. has completed the technology transfer for its VELDONA project, triggering a $600,000 license payment. The company also finished delivering 1,400 AI Nose systems to ASE under a three-year contract valued at $2.1 million. These developments highlight Ainos' focus on chemical intelligence and partner-funded development.
Ainos Completes VELDONA Transfer and ASE Delivery. Ainos Inc. has completed the technology transfer for its VELDONA project, triggering a $600,000 license payment. The company also finished delivering 1,400 AI Nose systems to ASE under a three-year contract valued at $2.1 million. These developments highlight Ainos' focus on chemical intelligence and partner-funded development.